Sweden
Dicot is a burgeoning player in the pharmaceutical industry, established in 2018 and headquartered in Sweden. Focused on enhancing sexual health, their mission is succinctly encapsulated in their slogan: "Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health."
Specializing in the treatment of erectile dysfunction and premature ejaculation, Dicot's primary product, LIB-01, is currently in the pre-clinical development stage. This highlights their commitment to addressing prevalent yet often under-discussed health issues within the Health Care and Lifestyle sectors, while leveraging their capabilities in pharmaceutical Manufacturing.
The company recently secured a kr250.00K grant investment in late June 2023 from Almi Invest, demonstrating external confidence in their innovative potential. This external support underscores Dicot's growth trajectory as they continue to develop solutions that promise to significantly improve quality of life.
